TTR and cardiac amyloidosis: In addition, Castaño et al. reported that transthyretin cardiac amyloidosis was prevalent in 16% of patients with severe AS undergoing transcatheter aortic valve implantation and was associated with a severe low-flow low-gradient AS phenotype despite only mildly reduced LVEF [41].